CarrRMOranuAKhungarV. Nonalcoholic fatty liver disease: pathophysiology and management. Gastroenterol Clin North Am. 2016;45(4):639-652. doi:10.1016/j.gtc.2016.07.003
2.
ChalasaniNYounossZLavineJE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.
3.
LeoniSTovoliFNapoliLSerioIFerriSBolondiL. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018;24(30):3361-3373.
4.
MarchesiniGDayCPDufourJF, et al. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388-1402.
5.
SpenglerEKLoombaR. Recommendations for diagnosis, referral for liver biopsy, and treatment for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc. 2015;90(9):1233-1243.
6.
ZiaMBianHGaoX. NAFLD and diabetes: two sides of the same coin? Rationale for gene-based personalized NAFLD treatment. Front Pharmacol. 2019;10:877.